Callan Capital LLC Has $464,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Callan Capital LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 882 shares of the healthcare conglomerate’s stock after purchasing an additional 49 shares during the quarter. Callan Capital LLC’s holdings in UnitedHealth Group were worth $464,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in UNH. Bray Capital Advisors grew its holdings in UnitedHealth Group by 0.5% during the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after acquiring an additional 50 shares during the last quarter. B.O.S.S. Retirement Advisors LLC grew its holdings in UnitedHealth Group by 16.7% during the 3rd quarter. B.O.S.S. Retirement Advisors LLC now owns 7,362 shares of the healthcare conglomerate’s stock worth $3,712,000 after acquiring an additional 1,054 shares during the last quarter. KFG Wealth Management LLC grew its holdings in UnitedHealth Group by 15.4% during the 3rd quarter. KFG Wealth Management LLC now owns 1,041 shares of the healthcare conglomerate’s stock worth $525,000 after acquiring an additional 139 shares during the last quarter. Nikulski Financial Inc. grew its holdings in UnitedHealth Group by 5.7% during the 3rd quarter. Nikulski Financial Inc. now owns 11,223 shares of the healthcare conglomerate’s stock worth $5,659,000 after acquiring an additional 608 shares during the last quarter. Finally, Exchange Traded Concepts LLC grew its holdings in UnitedHealth Group by 21,027.0% during the 3rd quarter. Exchange Traded Concepts LLC now owns 32,113 shares of the healthcare conglomerate’s stock worth $16,191,000 after acquiring an additional 31,961 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $1.49 during trading on Friday, reaching $495.35. 2,608,554 shares of the company’s stock traded hands, compared to its average volume of 4,508,195. The firm’s 50-day moving average is $485.84 and its 200 day moving average is $514.21. The company has a market capitalization of $455.76 billion, a P/E ratio of 30.28, a PEG ratio of 1.41 and a beta of 0.54. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.26 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on UNH shares. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Stephens reaffirmed an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.